Editor's Highlights — July 2026
International Journal of Dermatology · 2026-07 · 65 (7) · 1355-1356
DOI: 10.1111/ijd.70518 ↗At a glance
Editorial in International Journal of Dermatology, published online on 2026-05-27. Written by Lajos Kemény. Institution: Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. Major MEDLINE topics: Autoimmune Diseases, Skin Diseases, Vesiculobullous, Immune Checkpoint Inhibitors. 5 references.
Abstract (original language)
Targeted therapeutic advances in autoimmune blistering diseases have renewed attention to diagnostic precision, disease classification, and clinically relevant subgroups. In this issue, we focus on two aspects of this evolving field: recent developments in the diagnostics of autoimmune blistering diseases and the clinical features of checkpoint inhibitor–associated autoimmune blistering diseases and their treatment options. These contributions illustrate how therapeutic innovation, diagnostic progress, and recognition of emerging clinical contexts are closely interconnected.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
ORCID profiles: Lajos Kemény
Cite
APA
Kemény, L. (2026). Editor's Highlights — July 2026. International Journal of Dermatology, 65(7), 1355-1356. https://doi.org/10.1111/ijd.70518
Vancouver
Kemény L. Editor's Highlights — July 2026. International Journal of Dermatology. 2026;65(7):1355-1356. doi:10.1111/ijd.70518
BibTeX
@article{Kemny2026,
author = {Kemény, Lajos},
title = {Editor's Highlights — July 2026},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {7},
pages = {1355--1356},
doi = {10.1111/ijd.70518}
}
EUVIMED